Global Pneumococcal Vaccination Market Research Report 2026(Status and Outlook)

May 2026 | 132 pages | ID: GBADD487AB3BEN
Bosson Research

Abstracts

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.The pneumococcal vaccination market is driven by the increasing awareness of the importance of vaccination and the rising incidence of pneumococcal infections. Pneumococcal vaccines are crucial in preventing diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia, meningitis, and bacteremia. The rise in the geriatric population and the need for immunization against respiratory infections contribute to market growth as pneumococcal vaccines offer significant benefits in reducing morbidity and mortality. Moreover, advancements in vaccine technology, such as the introduction of conjugate vaccines for broader protection, have improved vaccine efficacy. However, the market also faces challenges, including vaccine supply constraints and the need for continuous research to address emerging pneumococcal serotypes and strains. Additionally, addressing vaccine hesitancy and increasing vaccination coverage in underserved populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable pneumococcal vaccines, collaborate with healthcare providers to promote vaccination recommendations, and address the challenges to meet the increasing demand for effective and accessible protection against pneumococcal infections.

The global Pneumococcal Vaccination market size was estimated at USD 9622.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.60% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Pneumococcal Vaccination market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Pneumococcal Vaccination market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pneumococcal Vaccination market.

Global Pneumococcal Vaccination Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Pfizer
• GSK
• MSD
• CDIBP
• WALVAX
• Sinovac
• Bio Kangtai

Market Segmentation (by Type)

• PPSV 23
• PCV 13
• PCV 10

Market Segmentation (by Application)

• Child
• Adult

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pneumococcal Vaccination Market

Overview of the regional outlook of the Pneumococcal Vaccination Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccination Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Pneumococcal Vaccination, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pneumococcal Vaccination
1.2 Key Market Segments
  1.2.1 Pneumococcal Vaccination Segment by Type
  1.2.2 Pneumococcal Vaccination Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PNEUMOCOCCAL VACCINATION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pneumococcal Vaccination Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Pneumococcal Vaccination Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PNEUMOCOCCAL VACCINATION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pneumococcal Vaccination Product Life Cycle
3.3 Global Pneumococcal Vaccination Sales by Manufacturers (2020-2025)
3.4 Global Pneumococcal Vaccination Revenue Market Share by Manufacturers (2020-2025)
3.5 Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pneumococcal Vaccination Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Pneumococcal Vaccination Market Competitive Situation and Trends
  3.8.1 Pneumococcal Vaccination Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pneumococcal Vaccination Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PNEUMOCOCCAL VACCINATION INDUSTRY CHAIN ANALYSIS

4.1 Pneumococcal Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL VACCINATION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pneumococcal Vaccination Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Pneumococcal Vaccination Market
5.7 ESG Ratings of Leading Companies

6 PNEUMOCOCCAL VACCINATION MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Vaccination Sales Market Share by Type (2020-2025)
6.3 Global Pneumococcal Vaccination Market Size by Type (2020-2025)
6.4 Global Pneumococcal Vaccination Price by Type (2020-2025)

7 PNEUMOCOCCAL VACCINATION MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Vaccination Market Sales by Application (2020-2025)
7.3 Global Pneumococcal Vaccination Market Size (M USD) by Application (2020-2025)
7.4 Global Pneumococcal Vaccination Sales Growth Rate by Application (2020-2025)

8 PNEUMOCOCCAL VACCINATION MARKET SALES BY REGION

8.1 Global Pneumococcal Vaccination Sales by Region
  8.1.1 Global Pneumococcal Vaccination Sales by Region
  8.1.2 Global Pneumococcal Vaccination Sales Market Share by Region
8.2 Global Pneumococcal Vaccination Market Size by Region
  8.2.1 Global Pneumococcal Vaccination Market Size by Region
  8.2.2 Global Pneumococcal Vaccination Market Size by Region
8.3 North America
  8.3.1 North America Pneumococcal Vaccination Sales by Country
  8.3.2 North America Pneumococcal Vaccination Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Pneumococcal Vaccination Sales by Country
  8.4.2 Europe Pneumococcal Vaccination Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Pneumococcal Vaccination Sales by Region
  8.5.2 Asia Pacific Pneumococcal Vaccination Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Pneumococcal Vaccination Sales by Country
  8.6.2 South America Pneumococcal Vaccination Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Pneumococcal Vaccination Sales by Region
  8.7.2 Middle East and Africa Pneumococcal Vaccination Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PNEUMOCOCCAL VACCINATION MARKET PRODUCTION BY REGION

9.1 Global Production of Pneumococcal Vaccination by Region(2020-2025)
9.2 Global Pneumococcal Vaccination Revenue Market Share by Region (2020-2025)
9.3 Global Pneumococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pneumococcal Vaccination Production
  9.4.1 North America Pneumococcal Vaccination Production Growth Rate (2020-2025)
  9.4.2 North America Pneumococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pneumococcal Vaccination Production
  9.5.1 Europe Pneumococcal Vaccination Production Growth Rate (2020-2025)
  9.5.2 Europe Pneumococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pneumococcal Vaccination Production (2020-2025)
  9.6.1 Japan Pneumococcal Vaccination Production Growth Rate (2020-2025)
  9.6.2 Japan Pneumococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pneumococcal Vaccination Production (2020-2025)
  9.7.1 China Pneumococcal Vaccination Production Growth Rate (2020-2025)
  9.7.2 China Pneumococcal Vaccination Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Pfizer
  10.1.1 Pfizer Basic Information
  10.1.2 Pfizer Pneumococcal Vaccination Product Overview
  10.1.3 Pfizer Pneumococcal Vaccination Product Market Performance
  10.1.4 Pfizer Business Overview
  10.1.5 Pfizer SWOT Analysis
  10.1.6 Pfizer Recent Developments
10.2 GSK
  10.2.1 GSK Basic Information
  10.2.2 GSK Pneumococcal Vaccination Product Overview
  10.2.3 GSK Pneumococcal Vaccination Product Market Performance
  10.2.4 GSK Business Overview
  10.2.5 GSK SWOT Analysis
  10.2.6 GSK Recent Developments
10.3 MSD
  10.3.1 MSD Basic Information
  10.3.2 MSD Pneumococcal Vaccination Product Overview
  10.3.3 MSD Pneumococcal Vaccination Product Market Performance
  10.3.4 MSD Business Overview
  10.3.5 MSD SWOT Analysis
  10.3.6 MSD Recent Developments
10.4 CDIBP
  10.4.1 CDIBP Basic Information
  10.4.2 CDIBP Pneumococcal Vaccination Product Overview
  10.4.3 CDIBP Pneumococcal Vaccination Product Market Performance
  10.4.4 CDIBP Business Overview
  10.4.5 CDIBP Recent Developments
10.5 WALVAX
  10.5.1 WALVAX Basic Information
  10.5.2 WALVAX Pneumococcal Vaccination Product Overview
  10.5.3 WALVAX Pneumococcal Vaccination Product Market Performance
  10.5.4 WALVAX Business Overview
  10.5.5 WALVAX Recent Developments
10.6 Sinovac
  10.6.1 Sinovac Basic Information
  10.6.2 Sinovac Pneumococcal Vaccination Product Overview
  10.6.3 Sinovac Pneumococcal Vaccination Product Market Performance
  10.6.4 Sinovac Business Overview
  10.6.5 Sinovac Recent Developments
10.7 Bio Kangtai
  10.7.1 Bio Kangtai Basic Information
  10.7.2 Bio Kangtai Pneumococcal Vaccination Product Overview
  10.7.3 Bio Kangtai Pneumococcal Vaccination Product Market Performance
  10.7.4 Bio Kangtai Business Overview
  10.7.5 Bio Kangtai Recent Developments

11 PNEUMOCOCCAL VACCINATION MARKET FORECAST BY REGION

11.1 Global Pneumococcal Vaccination Market Size Forecast
11.2 Global Pneumococcal Vaccination Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Pneumococcal Vaccination Market Size Forecast by Country
  11.2.3 Asia Pacific Pneumococcal Vaccination Market Size Forecast by Region
  11.2.4 South America Pneumococcal Vaccination Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Pneumococcal Vaccination by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Pneumococcal Vaccination Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Pneumococcal Vaccination by Type (2026-2035)
  12.1.2 Global Pneumococcal Vaccination Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Pneumococcal Vaccination by Type (2026-2035)
12.2 Global Pneumococcal Vaccination Market Forecast by Application (2026-2035)
  12.2.1 Global Pneumococcal Vaccination Sales (K MT) Forecast by Application
  12.2.2 Global Pneumococcal Vaccination Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pneumococcal Vaccination Market Size by Type (M USD)
Table 4. Global Pneumococcal Vaccination Market Size by Application
Table 5. Pneumococcal Vaccination Market Size Comparison by Region (M USD)
Table 6. Global Pneumococcal Vaccination Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccination Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pneumococcal Vaccination Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pneumococcal Vaccination Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccination as of 2025)
Table 11. Global Market Pneumococcal Vaccination Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Pneumococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Vaccination Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pneumococcal Vaccination Sales by Type (K MT)
Table 27. Global Pneumococcal Vaccination Market Size by Type (M USD)
Table 28. Global Pneumococcal Vaccination Sales (K MT) by Type (2020-2025)
Table 29. Global Pneumococcal Vaccination Sales Market Share by Type (2020-2025)
Table 30. Global Pneumococcal Vaccination Market Size (M USD) by Type (2020-2025)
Table 31. Global Pneumococcal Vaccination Market Share by Type (2020-2025)
Table 32. Global Pneumococcal Vaccination Price (USD/KG) by Type (2020-2025)
Table 33. Global Pneumococcal Vaccination Sales (K MT) by Application
Table 34. Global Pneumococcal Vaccination Market Size by Application
Table 35. Global Pneumococcal Vaccination Sales by Application (2020-2025) & (K MT)
Table 36. Global Pneumococcal Vaccination Sales Market Share by Application (2020-2025)
Table 37. Global Pneumococcal Vaccination Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pneumococcal Vaccination Market Share by Application (2020-2025)
Table 39. Global Pneumococcal Vaccination Sales Growth Rate by Application (2020-2025)
Table 40. Global Pneumococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 41. Global Pneumococcal Vaccination Sales Market Share by Region (2020-2025)
Table 42. Global Pneumococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pneumococcal Vaccination Market Size by Region (2020-2025)
Table 44. North America Pneumococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 45. North America Pneumococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pneumococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pneumococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pneumococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pneumococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pneumococcal Vaccination Sales by Country (2020-2025) & (K MT)
Table 51. South America Pneumococcal Vaccination Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pneumococcal Vaccination Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pneumococcal Vaccination Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pneumococcal Vaccination Production (K MT) by Region(2020-2025)
Table 55. Global Pneumococcal Vaccination Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pneumococcal Vaccination Revenue Market Share by Region (2020-2025)
Table 57. Global Pneumococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pneumococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pneumococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pneumococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pneumococcal Vaccination Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Pneumococcal Vaccination Product Overview
Table 64. Pfizer Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Pneumococcal Vaccination Product Overview
Table 70. GSK Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. MSD Basic Information
Table 75. MSD Pneumococcal Vaccination Product Overview
Table 76. MSD Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. MSD Business Overview
Table 78. MSD SWOT Analysis
Table 79. MSD Recent Developments
Table 80. CDIBP Basic Information
Table 81. CDIBP Pneumococcal Vaccination Product Overview
Table 82. CDIBP Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CDIBP Business Overview
Table 84. CDIBP Recent Developments
Table 85. WALVAX Basic Information
Table 86. WALVAX Pneumococcal Vaccination Product Overview
Table 87. WALVAX Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. WALVAX Business Overview
Table 89. WALVAX Recent Developments
Table 90. Sinovac Basic Information
Table 91. Sinovac Pneumococcal Vaccination Product Overview
Table 92. Sinovac Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sinovac Business Overview
Table 94. Sinovac Recent Developments
Table 95. Bio Kangtai Basic Information
Table 96. Bio Kangtai Pneumococcal Vaccination Product Overview
Table 97. Bio Kangtai Pneumococcal Vaccination Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bio Kangtai Business Overview
Table 99. Bio Kangtai Recent Developments
Table 100. Global Pneumococcal Vaccination Sales Forecast by Region (2026-2035) & (K MT)
Table 101. Global Pneumococcal Vaccination Market Size Forecast by Region (2026-2035) & (M USD)
Table 102. North America Pneumococcal Vaccination Sales Forecast by Country (2026-2035) & (K MT)
Table 103. North America Pneumococcal Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 104. Europe Pneumococcal Vaccination Sales Forecast by Country (2026-2035) & (K MT)
Table 105. Europe Pneumococcal Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 106. Asia Pacific Pneumococcal Vaccination Sales Forecast by Region (2026-2035) & (K MT)
Table 107. Asia Pacific Pneumococcal Vaccination Market Size Forecast by Region (2026-2035) & (M USD)
Table 108. South America Pneumococcal Vaccination Sales Forecast by Country (2026-2035) & (K MT)
Table 109. South America Pneumococcal Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 110. Middle East and Africa Pneumococcal Vaccination Sales Forecast by Country (2026-2035) & (Units)
Table 111. Middle East and Africa Pneumococcal Vaccination Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Global Pneumococcal Vaccination Sales Forecast by Type (2026-2035) & (K MT)
Table 113. Global Pneumococcal Vaccination Market Size Forecast by Type (2026-2035) & (M USD)
Table 114. Global Pneumococcal Vaccination Price Forecast by Type (2026-2035) & (USD/KG)
Table 115. Global Pneumococcal Vaccination Sales (K MT) Forecast by Application (2026-2035)
Table 116. Global Pneumococcal Vaccination Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Pneumococcal Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Vaccination Market Size (M USD), 2025-2035
Figure 5. Global Pneumococcal Vaccination Market Size (M USD) (2020-2035)
Figure 6. Global Pneumococcal Vaccination Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Vaccination Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pneumococcal Vaccination Product Life Cycle
Figure 13. Pneumococcal Vaccination Sales Share by Manufacturers in 2025
Figure 14. Global Pneumococcal Vaccination Revenue Share by Manufacturers in 2025
Figure 15. Pneumococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pneumococcal Vaccination Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccination Revenue in 2025
Figure 18. Industry Chain Map of Pneumococcal Vaccination
Figure 19. Global Pneumococcal Vaccination Market PEST Analysis
Figure 20. Global Pneumococcal Vaccination Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pneumococcal Vaccination Market Share by Type
Figure 27. Sales Market Share of Pneumococcal Vaccination by Type (2020-2025)
Figure 28. Sales Market Share of Pneumococcal Vaccination by Type in 2025
Figure 29. Market Share of Pneumococcal Vaccination by Type (2020-2025)
Figure 30. Market Share of Pneumococcal Vaccination by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pneumococcal Vaccination Market Share by Application
Figure 33. Global Pneumococcal Vaccination Sales Market Share by Application (2020-2025)
Figure 34. Global Pneumococcal Vaccination Sales Market Share by Application in 2025
Figure 35. Global Pneumococcal Vaccination Market Share by Application (2020-2025)
Figure 36. Global Pneumococcal Vaccination Market Share by Application in 2025
Figure 37. Global Pneumococcal Vaccination Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pneumococcal Vaccination Sales Market Share by Region (2020-2025)
Figure 39. Global Pneumococcal Vaccination Market Size by Region (2020-2025)
Figure 40. North America Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pneumococcal Vaccination Sales Market Share by Country in 2024
Figure 43. North America Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pneumococcal Vaccination Market Size by Country in 2024
Figure 45. U.S. Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pneumococcal Vaccination Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pneumococcal Vaccination Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pneumococcal Vaccination Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pneumococcal Vaccination Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pneumococcal Vaccination Sales Market Share by Country in 2024
Figure 53. Europe Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pneumococcal Vaccination Market Size by Country in 2024
Figure 55. Germany Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pneumococcal Vaccination Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pneumococcal Vaccination Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pneumococcal Vaccination Market Size by Region in 2024
Figure 68. China Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pneumococcal Vaccination Sales and Growth Rate (K MT)
Figure 79. South America Pneumococcal Vaccination Sales Market Share by Country in 2024
Figure 80. South America Pneumococcal Vaccination Market Size and Growth Rate (M USD)
Figure 81. South America Pneumococcal Vaccination Market Size by Country in 2024
Figure 82. Brazil Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pneumococcal Vaccination Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pneumococcal Vaccination Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pneumococcal Vaccination Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pneumococcal Vaccination Market Size by Region in 2024
Figure 92. Saudi Arabia Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pneumococcal Vaccination Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pneumococcal Vaccination Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pneumococcal Vaccination Production Market Share by Region (2020-2025)
Figure 103. North America Pneumococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pneumococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pneumococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pneumococcal Vaccination Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pneumococcal Vaccination Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pneumococcal Vaccination Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pneumococcal Vaccination Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pneumococcal Vaccination Market Share Forecast by Type (2026-2035)
Figure 111. Global Pneumococcal Vaccination Sales Forecast by Application (2026-2035)
Figure 112. Global Pneumococcal Vaccination Market Share Forecast by Application (2026-2035)